S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
Log in
NASDAQ:INO

Inovio Pharmaceuticals News Headlines

$9.00
-0.10 (-1.10 %)
(As of 01/22/2021 04:54 PM ET)
Add
Compare
Today's Range
$8.81
Now: $9.00
$9.30
50-Day Range
$8.85
MA: $10.19
$12.60
52-Week Range
$3.14
Now: $9.00
$33.79
Volume13.42 million shs
Average Volume10.58 million shs
Market Capitalization$1.52 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.08

Headlines

Inovio Pharmaceuticals (NASDAQ INO) News Headlines Today

Source:
SourceHeadline
Inovio Pharmaceuticals (NASDAQ:INO) Upgraded by Zacks Investment Research to HoldInovio Pharmaceuticals (NASDAQ:INO) Upgraded by Zacks Investment Research to Hold
marketbeat.com - January 21 at 2:15 AM
Zacks Investment Research Lowers Inovio Pharmaceuticals (NASDAQ:INO) to SellZacks Investment Research Lowers Inovio Pharmaceuticals (NASDAQ:INO) to Sell
marketbeat.com - December 18 at 1:55 AM
How to Invest After a Turbulent 2020 Election (INO)How to Invest After a Turbulent 2020 Election (INO)
marketbeat.com - November 23 at 5:51 PM
Inovio Pharmaceuticals (NASDAQ:INO) Downgraded by Roth Capital to SellInovio Pharmaceuticals (NASDAQ:INO) Downgraded by Roth Capital to Sell
marketbeat.com - November 17 at 7:47 AM
BidaskClub Downgrades Inovio Pharmaceuticals (NASDAQ:INO) to SellBidaskClub Downgrades Inovio Pharmaceuticals (NASDAQ:INO) to Sell
marketbeat.com - October 22 at 2:25 AM
Roth Capital Trims Inovio Pharmaceuticals (NASDAQ:INO) Target Price to $8.00Roth Capital Trims Inovio Pharmaceuticals (NASDAQ:INO) Target Price to $8.00
marketbeat.com - September 28 at 4:18 PM
3 Vaccine Stocks That May Be Flying Under Your Radar3 Vaccine Stocks That May Be Flying Under Your Radar
marketbeat.com - September 11 at 10:29 AM
Potential Wins at Inovio Pharmaceuticals (NASDAQ: INO)Potential Wins at Inovio Pharmaceuticals (NASDAQ: INO)
marketbeat.com - September 3 at 7:03 PM
Should You Buy Novavax or Inovio?  (INO)Should You Buy Novavax or Inovio? (INO)
marketbeat.com - August 31 at 4:57 PM
Inovio Pharmaceuticals (NASDAQ:INO) PT Lowered to $16.00Inovio Pharmaceuticals (NASDAQ:INO) PT Lowered to $16.00
marketbeat.com - August 11 at 3:15 PM
Tempted by Inovio Pharmaceuticals (NASDAQ:INO)? (INO)Tempted by Inovio Pharmaceuticals (NASDAQ:INO)? (INO)
marketbeat.com - August 11 at 10:27 AM
Buckle Up, Moderna (NASDAQ: MRNA) Reported Their Vaccine Can Create COVID-Antibodies (INO)Buckle Up, Moderna (NASDAQ: MRNA) Reported Their Vaccine Can Create COVID-Antibodies (INO)
marketbeat.com - August 3 at 2:09 PM
BioXcel Technologies (NASDAQ: BTAI) Offers Growth Without Coronavirus Risk (INO)BioXcel Technologies (NASDAQ: BTAI) Offers Growth Without Coronavirus Risk (INO)
marketbeat.com - August 3 at 2:09 PM
Pfizer (NYSE: PFE) Shares Get Much Needed Boost (INO)Pfizer (NYSE: PFE) Shares Get Much Needed Boost (INO)
marketbeat.com - August 3 at 2:09 PM
Inovio (NASDAQ: INO) is Nosing Its Way Into the U.S. Vaccine Plans (INO)Inovio (NASDAQ: INO) is Nosing Its Way Into the U.S. Vaccine Plans (INO)
marketbeat.com - August 3 at 2:08 PM
3 Companies to Bet On as the World Races For a Vaccine (INO)3 Companies to Bet On as the World Races For a Vaccine (INO)
marketbeat.com - August 3 at 2:08 PM
Inovio Pharmaceuticals (NASDAQ:INO) Stock Price Down 6.4%Inovio Pharmaceuticals (NASDAQ:INO) Stock Price Down 6.4%
americanbankingnews.com - January 21 at 8:22 PM
Why Editas Medicine, Inovio, Dyne, and CytomX Stocks Are Falling TodayWhy Editas Medicine, Inovio, Dyne, and CytomX Stocks Are Falling Today
fool.com - January 21 at 12:23 PM
Inovio Pharma Prices Public Offering Of 17.70 Mln Shares At $8.50/shr - Quick FactsInovio Pharma Prices Public Offering Of 17.70 Mln Shares At $8.50/shr - Quick Facts
nasdaq.com - January 21 at 1:23 AM
INOVIO Announces Proposed Public Offering of Common StockINOVIO Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 20 at 8:22 PM
Inovio’s (INO) INO-4800 can be a Valuable Vaccine Arsenal Upon FDA ApprovalInovio’s (INO) INO-4800 can be a Valuable Vaccine Arsenal Upon FDA Approval
finance.yahoo.com - January 20 at 3:21 PM
Here Are the Early-Stage COVID Vaccine Stocks to Watch in 2021Here Are the Early-Stage COVID Vaccine Stocks to Watch in 2021
nasdaq.com - January 17 at 6:50 PM
Noteworthy Friday Option Activity: INO, PYPL, FSLYNoteworthy Friday Option Activity: INO, PYPL, FSLY
nasdaq.com - January 16 at 9:01 AM
Inovio: Advaccine Deal Is a Positive but Not a Game Changer, Analyst SaysInovio: Advaccine Deal Is a Positive but Not a Game Changer, Analyst Says
finance.yahoo.com - January 7 at 1:47 AM
INOVIO Announces Positive Efficacy Results For Phase 2 Trial Of VGX-3100 - Quick FactsINOVIO Announces Positive Efficacy Results For Phase 2 Trial Of VGX-3100 - Quick Facts
nasdaq.com - January 6 at 10:43 AM
INOVIOs VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18
finance.yahoo.com - January 6 at 10:43 AM
Inovio Pharmaceuticals (NASDAQ:INO) Trading Up 9.9%Inovio Pharmaceuticals (NASDAQ:INO) Trading Up 9.9%
americanbankingnews.com - January 4 at 8:52 PM
Inovio partners with Advaccine to make and sell COVID-19 vaccine in ChinaInovio partners with Advaccine to make and sell COVID-19 vaccine in China
nasdaq.com - January 4 at 1:29 PM
Inovio partners with Advaccine to commercialize COVID-19 vaccine in ChinaInovio partners with Advaccine to commercialize COVID-19 vaccine in China
reuters.com - January 4 at 1:29 PM
Inovio Strikes $100M Coronavirus Vaccine Licensing Deal With Chinas AdvaccineInovio Strikes $100M Coronavirus Vaccine Licensing Deal With China's Advaccine
finance.yahoo.com - January 4 at 1:29 PM
INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater ChinaINOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China
finance.yahoo.com - January 4 at 8:28 AM
Inovio to partner with Chinese biotech on COVID-19 vaccine candidate in Greater ChinaInovio to partner with Chinese biotech on COVID-19 vaccine candidate in Greater China
finance.yahoo.com - January 4 at 8:28 AM
Inovio Pharmaceuticals (NASDAQ:INO)  Shares Down 6.4% Inovio Pharmaceuticals (NASDAQ:INO) Shares Down 6.4%
americanbankingnews.com - December 28 at 9:18 PM
Why Inovio Stock Sank TodayWhy Inovio Stock Sank Today
finance.yahoo.com - December 28 at 5:38 PM
February 2021 Options Now Available For Inovio PharmaceuticalsFebruary 2021 Options Now Available For Inovio Pharmaceuticals
nasdaq.com - December 25 at 8:17 AM
Is Inovio Pharmaceuticals (INO) a Smart Long-term Buy?Is Inovio Pharmaceuticals (INO) a Smart Long-term Buy?
finance.yahoo.com - December 25 at 8:17 AM
Are Options Traders Betting on a Big Move in Inovio Pharmaceuticals (INO) Stock?Are Options Traders Betting on a Big Move in Inovio Pharmaceuticals (INO) Stock?
finance.yahoo.com - December 17 at 12:37 PM
Is INO A Good Stock To Buy Now?Is INO A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 8:52 AM
INOVIO to Develop DNA-encoded Monoclonal Antibody (dMAb®) Candidates to Treat COVID-19 with Funding from the Defense Advanced Research Projects Agency (DARPA) and the Department of Defenses (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)INOVIO to Develop DNA-encoded Monoclonal Antibody (dMAb®) Candidates to Treat COVID-19 with Funding from the Defense Advanced Research Projects Agency (DARPA) and the Department of Defense's (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)
finance.yahoo.com - December 15 at 9:20 AM
These 5 Mid-Cap Healthcare Stocks Had the Best Gains in 2020These 5 Mid-Cap Healthcare Stocks Had the Best Gains in 2020
finance.yahoo.com - December 11 at 7:28 AM
INOVIO, Advaccine: First Subject Dosed In Phase 2 Trial Of COVID-19 Vaccine Candidate In ChinaINOVIO, Advaccine: First Subject Dosed In Phase 2 Trial Of COVID-19 Vaccine Candidate In China
nasdaq.com - December 10 at 9:12 AM
Can Inovio Survive a Last-Place Finish in the Race to a COVID 19 Vaccine?Can Inovio Survive a Last-Place Finish in the Race to a COVID 19 Vaccine?
finance.yahoo.com - December 9 at 11:11 PM
Inovio: VGX-3100 Showed Positive Phase 2 Efficacy In Treatment Of Precancerous Anal DysplasiaInovio: VGX-3100 Showed Positive Phase 2 Efficacy In Treatment Of Precancerous Anal Dysplasia
nasdaq.com - December 9 at 6:11 PM
Inovio doses first volunteer as part of its COVID-19 vaccine mid-stage trialInovio doses first volunteer as part of its COVID-19 vaccine mid-stage trial
nasdaq.com - December 7 at 5:48 PM
Inovio starts dosing participants in mid-stage COVID-19 vaccine trialInovio starts dosing participants in mid-stage COVID-19 vaccine trial
finance.yahoo.com - December 7 at 5:48 PM
Reality Hits Home for Shares of Inovio PharmaceuticalsReality Hits Home for Shares of Inovio Pharmaceuticals
investorplace.com - December 4 at 6:08 PM
Interesting INO Put And Call Options For January 2021Interesting INO Put And Call Options For January 2021
nasdaq.com - December 3 at 4:46 PM
Inovio signs COVID-19 vaccine manufacturing deal with Japans KanekaInovio signs COVID-19 vaccine manufacturing deal with Japan's Kaneka
finance.yahoo.com - December 3 at 4:46 PM
INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A.INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A.
finance.yahoo.com - December 3 at 8:31 AM
Should You Follow Robinhood Investors Into These 2 Risky Coronavirus Stocks?Should You Follow Robinhood Investors Into These 2 Risky Coronavirus Stocks?
finance.yahoo.com - December 2 at 7:44 AM
3 Long-Shot Coronavirus Vaccine Stocks to Watch in December3 Long-Shot Coronavirus Vaccine Stocks to Watch in December
finance.yahoo.com - November 24 at 8:17 AM
INOVIO Announces Dosing of First Subject in Phase 1/2 Clinical Trial for INO-3107, its DNA Medicine to Treat a Rare Disease Recurrent Respiratory Papillomatosis (RRP)INOVIO Announces Dosing of First Subject in Phase 1/2 Clinical Trial for INO-3107, its DNA Medicine to Treat a Rare Disease Recurrent Respiratory Papillomatosis (RRP)
finance.yahoo.com - November 23 at 10:01 AM
Why Inovio Stock Slid TodayWhy Inovio Stock Slid Today
finance.yahoo.com - November 20 at 8:00 PM
Thinking about trading options or stock in Pfizer, Inovio Pharmaceuticals, Alibaba, General Electric, or Nio?Thinking about trading options or stock in Pfizer, Inovio Pharmaceuticals, Alibaba, General Electric, or Nio?
marketwatch.com - November 20 at 2:59 PM
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual MeetingINOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting
finance.yahoo.com - November 20 at 9:56 AM
Is Inovio Back in the Coronavirus Vaccine Race?Is Inovio Back in the Coronavirus Vaccine Race?
finance.yahoo.com - November 20 at 9:56 AM
Has the Clock Struck Midnight for This Cinderella Coronavirus Stock?Has the Clock Struck Midnight for This Cinderella Coronavirus Stock?
finance.yahoo.com - November 19 at 11:30 PM
Inovio: The COVID Vaccine Race Is Not Yet OverInovio: The COVID Vaccine Race Is Not Yet Over
seekingalpha.com - November 19 at 1:29 PM
Inovio Analyst: COVID-19 Competition Could Be Too GreatInovio Analyst: COVID-19 Competition Could Be Too Great
finance.yahoo.com - November 17 at 9:11 PM
BUZZ-U.S. STOCKS ON THE MOVE-Uber, Adamis Pharmaceuticals, Alterity Therapeutics, VirginBUZZ-U.S. STOCKS ON THE MOVE-Uber, Adamis Pharmaceuticals, Alterity Therapeutics, Virgin
nasdaq.com - November 16 at 3:06 PM
Inovio Stock Launches After Biotech Begins Coronavirus Vaccine TestInovio Stock Launches After Biotech Begins Coronavirus Vaccine Test
finance.yahoo.com - November 16 at 3:06 PM
INOVIO To Begin Phase 2 Of Its Phase 2/3 Clinical Trial For COVID-19 DNA Vaccine CandidateINOVIO To Begin Phase 2 Of Its Phase 2/3 Clinical Trial For COVID-19 DNA Vaccine Candidate
nasdaq.com - November 16 at 10:05 AM
FDA Lifts Partial Clinical Hold On Inovios Phase 2 Investigational Coronavirus Vaccine StudyFDA Lifts Partial Clinical Hold On Inovio's Phase 2 Investigational Coronavirus Vaccine Study
benzinga.com - November 16 at 10:05 AM
FDA clears Inovio to begin mid-stage testing of its Covid-19 vaccine candidate, but one hurdle remainsFDA clears Inovio to begin mid-stage testing of its Covid-19 vaccine candidate, but one hurdle remains
bizjournals.com - November 16 at 10:05 AM
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of DefenseINOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense
finance.yahoo.com - November 16 at 10:04 AM
Inovio to begin mid-stage study of COVID-19 vaccine candidateInovio to begin mid-stage study of COVID-19 vaccine candidate
finance.yahoo.com - November 16 at 10:04 AM
This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.